|
|
Volumn 2, Issue 2, 2001, Pages 85-89
|
|
Selected highlights from the 50th Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001
|
|
Author keywords
Cardiology; Clinical trials; Congress; Meeting report
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALAGEBRIUM;
ANTIHYPERTENSIVE AGENT;
CARVEDILOL;
CLOPIDOGREL;
ENDOTHELIN RECEPTOR ANTAGONIST;
NEW DRUG;
PLACEBO;
PRAVASTATIN;
TEZOSENTAN;
TROPONIN;
UNCLASSIFIED DRUG;
ACCURACY;
ACUTE HEART FAILURE;
ADULT;
ATHEROSCLEROSIS;
BLEEDING;
BLOOD PRESSURE;
BLOOD VESSEL COMPLIANCE;
CARDIOLOGY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
DATA ANALYSIS;
DRUG SAFETY;
FEMALE;
HEART ARRHYTHMIA;
HEART FAILURE;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
INFLAMMATION;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL SOCIETY;
METHODOLOGY;
PACEMAKER;
RESTENOSIS;
RISK ASSESSMENT;
SCORING SYSTEM;
STENT;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
UNITED STATES;
UNSTABLE ANGINA PECTORIS;
|
|
EID: 0035013316
PISSN: 14686708
EISSN: None
Source Type: Journal
DOI: 10.1186/CVM-2-2-085 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
